Grace Colón succeeds Amy Abernethy on the CareDx Board
Dr. Colón has served as President, Chief Executive Officer and Director of
“Dr. Colón brings over 25 years of experience in biopharma, genomics, healthcare and industrial biotechnology and has committed the last 6 years to developing transformative therapies for cardiac conditions. Her contributions will be invaluable as we further develop the
“I am excited to work with the
For more information, please visit: www.CareDx.com.
Chief Commercial Officer
Source: CareDx, Inc.